Nectero Medical is a biotechnology company that focuses on developing treatments intended for aneurysmal disease, which is a condition that causes patients to suffer from aneurysms. The company’s flagship product is the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST®) System. Nectero EAST is designed for aneurysm management, particularly for small to medium-sized abdominal aortic aneurysms (AAA). It is an investigational system that strives to deliver pentagalloyl glucose directly into the aneurysmal wall with the goal of offering patients a minimally invasive alternative to traditional treatments.

Register for Details

For more details on financing and valuation for Nectero Medical, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Nectero Medical

Forge green plus iconForge green minus icon

What is Nectero Medical's IPO price?

The IPO price for Nectero Medical will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Nectero Medical?

Nectero Medical is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Nectero Medical shares pre-IPO?

If you own Nectero Medical pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Nectero Medical a publicly traded company?

Nectero Medical is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was Nectero Medical founded?

Nectero Medical was founded in 2017.

Who are Nectero Medical's major investors?

Norwest Venture Partners
Aphelion Capital
Boston Scientific
BioStar Capital
Cadence Healthcare Ventures
Park Partners Capital
Updated on: May 25, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.